Article Per Year (5 Year)
p-Index From 2020 - 2025
0.659
P-Index
This Author published in this journals
All Journal Biomedical Journal of Indonesia jurnal syntax admiration Jurnal Ilmu Kesehatan Indonesia (JIKSI)
Irvan Medison
Fakultas Kedokteran Universitas Andalas
Aerospace Engineering Automotive Engineering Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Computer Science & IT Education Electrical & Electronics Engineering Engineering Immunology & microbiology Industrial & Manufacturing Engineering Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Mathematics Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Antiviral Therapy in Corona Virus Disease-19 (Covid-19) Azka, Laisa; Irvan Medison; Dessy Mizarti
Biomedical Journal of Indonesia Vol. 7 No. 2 (2021): Biomedical Journal of Indonesia
Publisher : Fakultas Kedokteran Universitas Sriwijaya (Faculty of Medicine, Universitas Sriwijaya) Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32539/bji.v7i2.520

Abstract

Coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV), which was first identified in Wuhan City, Hubei Province, PRC. The total number of COVID-19 cases worldwide has reached 102 million cases with 54 million cases recovered and 2.3 million cases dead. Handling for this pandemic is still being carried out. In Indonesia, the antiviral drugs used are those that meet the Emergency Use Authorization (EUA) requirements, and are included in the COVID-19 management guidelines issued by the Ministry of Health. Antiviral options used are Oseltamivir, Favifirapir, Remdesivir. Until now, the use of antivirus is still being researched regarding the effectiveness and security of the antivirus used. Oseltamivir is used as an antiviral for COVID-19 with a mild clinical course, Favifirapir is used for mild to moderate clinical cases of COVID-19. For the use of remdesivir in COVID-19 patients with severe and critis clinical conditions.
Kajian Terkini CoronaVirus Disease 2019 (COVID-19) Chicy Widya Morfi; Ahmad Junaidi; Elsesmita Elsesmita; Diana Nur Asrini; Dya Mulya Lestari; Irvan Medison; Russilawati Russilawati; Fauzar Fauzar; Roza Kurniati; Finny Fitry Yani
Jurnal Ilmu Kesehatan Indonesia Vol 1 No 1 (2020): Maret 2020
Publisher : Fakultas Kedokteran, Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (482.016 KB) | DOI: 10.25077/jikesi.v1i1.13

Abstract

The COVID-19 outbreak in Wuhan, Hubei Province, China, caused by a newly known coronavirus strain, SARS-CoV-2, up to March 3th, 2020, has caused 90.870 confirmed cases to be reported from 72 countries (including Indonesia) with 3.112 deaths (CFR 3,4%). Upper airway swab and lower airway aspirate specimens from suspected patients are required for examination by the RT-PCR microbiological method for establishing COVID-19. There are no specific antivirals for the management of COVID-19. On January, 30th, 2020 WHO has established Covid-19 as the Public Health Emergency of International Concern (PHEIC), but the increase in the number of cases is fast enough so that on March,11th 2020, WHO has established Covid-19 as a pandemic.
Community Acquired Pneumonia pada Lansia Harry Pasca Rullian; Irvan Medison; Dessy Mizarti; Dewi Wahyu F
Jurnal Syntax Admiration Vol. 5 No. 5 (2024): Jurnal Syntax Admiration
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/jsa.v5i5.1125

Abstract

Community Acquired Pneumonia (CAP) causes high morbidity and mortality worldwide, especially in elderly patients. Establishing a diagnosis of CAP in elderly patients is a challenge for clinicians considering that the symptoms are not always typical and specific. The following is a case report of a 72-year-old woman with a diagnosis of CAP without any previous complaints of shortness of breath. There is an infiltrate on chest X-ray and symptoms of cough, productive sputum, fever, and leukocytosis confirm the diagnosis of CAP in this patient. The patient was given antibiotic levofloxacin 1 x 750 mg until Klebsiella pneumoniae was found in the sputum culture results.
Co-Authors Ahmad Junaidi Azka, Laisa Chicy WIdya Morfi Dessy Mizarti Dessy Mizarti Dewi Wahyu F Diana Nur Asrini Dya Mulya Lestari Elsesmita Elsesmita Fauzar Fauzar Finny Fitry Yani Harry Pasca Rullian Roza Kurniati Russilawati, Russilawati